https://clinicaltrials.gov/ct2/show/NCT03894579?type=Intr&cond=Psoriasis&lupd_s=03%2F14%2F2019&lupd_d=14
Condition : Moderate to Severe Plaque Psoriasis
Intervention : Biological: Study Product: SNK01
Sponsor : NKMax America, Inc.
Recruiting
Autologous Natural Killer Cells in Subjects With Moderate to Severe Psoriasis
NCT03894579
Thu, 28 Mar 2019 12:00:00 EDT
Last Update Posted: 03/28/19 09:26AM